From clinical trial to clinical experience: Lecanemab therapy in a real-world case series
{{output}}
The approval of anti-amyloid therapies has expanded therapeutic options for patients with Alzheimer's disease (AD), but the pivotal trials that proved their efficacy restrict their applicability to a selected patient population. We describe a case series of s... ...
